 JPMorgan Chase Co. increased its stake in Lineage Cell Therapeutics, Inc. NYSEAMERICAN:LCTX by 26.1 during the 1st quarter, according to its most recent filing with the Securities Exchange Commission. The fund owned 178,846 shares of the companys stock after buying an additional 37,000 shares during the period. JPMorgan Chase Co. owned 0.12 ... 